Respiratory Infectious Disease Antigen Test

Rapid immunoassay-based detection system for respiratory pathogen antigens. Provides quick diagnostic results for common respiratory infections in clinical settings.

Rapid diagnostic test for respiratory infections including influenza and other respiratory pathogens. Supports quick diagnosis in clinical settings.

Rapid immunochromatographic assay for antigen detection in patient samples. Provides quick results for various respiratory and infectious disease pathogens.

Rapid antigen/antibody test for respiratory disease detection with fast, reliable results for clinical screening.

Rapid immunochromatographic assay for qualitative detection of respiratory pathogens in patient samples. Point-of-care diagnostic test for respiratory infection screening.

Utilizes Colloidal Gold Immunochromatographic Assay and Fluorescence Immunoassay technologies to support rapid antigen detection for Influenza A/B, RSV, COVID-19, ADV, HMPV, PIV, and co-infection panels. Designed for professional point-of-care testing (POCT) environments in hospital emergency departments and public health programs. Compatible with nasopharyngeal and nasal swab samples with CE-IVD compliant formats and shelf life up to 36 months at 2–30°C.

A rapid diagnostic test kit for detecting respiratory infectious diseases using immunological detection technology. The test requires no equipment and provides easy-to-use sample processing and result reading.

A rapid self-test kit for detecting antigens of Influenza A, Influenza B, COVID-19, and RSV. Provides quick results for respiratory viral infections.

Respiratory disease rapid test kits that detect a wide range of pathogens including influenza A/B, RSV, SARS-CoV-2 and more. Using Colloidal Gold and Fluorescence Immunoassay technologies with multiplex respiratory panel formats available, they support early intervention and point-of-care respiratory testing.

Rapid immunochromatographic test kit for simultaneous detection of Influenza A and B virus antigens in respiratory specimens. Delivers results within 10-15 minutes, enabling quick clinical decision-making in point-of-care settings. Suitable for emergency departments, urgent care clinics, and routine screening during flu seasons.

Point-of-care diagnostic test for rapid detection of influenza A and B viruses. Used in respiratory disease screening in hospitals and clinics.

This kit is used for in vitro qualitative detection of COVID-19, Influenza A virus, Influenza B virus, Respiratory syncytial virus, Adenovirus, M. Pneumoniae, Chlamydia pneumoniae, Human Metapneumovirus, Parainfluenza virus 1/3, and Parainfluenza virus 2 antigen in human nasal swab samples. The kit uses an immunochromatographic method with latex microspheres where treated samples are applied to test cards and viral antigens form complexes with labeled antibodies. The complexes move along a nitrocellulose membrane and are captured by pre-coated monoclonal antibodies, producing a blue reaction line in the detection area if antigen is present above the minimum detection limit. A blue reaction line in the quality control area indicates the chromatography process is normal.